Selective gene therapy for proliferative disorders: sense and antisense

Nat Med. 1996 Jun;2(6):634-5. doi: 10.1038/nm0696-634.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Arteriosclerosis / genetics
  • Arteriosclerosis / pathology
  • Arteriosclerosis / therapy*
  • Cell Division / drug effects*
  • Cyclic AMP / metabolism
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Genes, ras
  • Genetic Therapy / methods*
  • Humans
  • Mice
  • Models, Biological
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Neoplasms / therapy*
  • Oligonucleotides, Antisense / pharmacology*
  • Oligonucleotides, Antisense / therapeutic use
  • Protein Serine-Threonine Kinases / drug effects
  • Proto-Oncogene Proteins / drug effects
  • Proto-Oncogene Proteins c-raf
  • RNA, Messenger / drug effects
  • Signal Transduction / physiology

Substances

  • Oligonucleotides, Antisense
  • Proto-Oncogene Proteins
  • RNA, Messenger
  • Cyclic AMP
  • Protein Serine-Threonine Kinases
  • Proto-Oncogene Proteins c-raf
  • Cyclic AMP-Dependent Protein Kinases